VALARTH See Fortis Healthcare in the appOpen in app
FORTIS · NSE · Hospital

Fortis Healthcare Ltd

What the numbers mean, from its filings and the exchange. Data as of 13 Oct 2026.
Mid Cap · AMFI list Jan-Jun 2026 · Vendor sector: Healthcare
cheap low confidence No valuation within 120 days; P/E 56.6 vs peers 78.6 (3rd of 9); P/B 6.5 vs peers 10.2 (3rd of 8).
Statements through FY2026Prices adjusted for corporate actionsNot yet reviewed by the adversarial model

What is Fortis Healthcare's share price today?

Fortis Healthcare last traded at ₹752.70 on the NSE, as of 13 Oct 2026, 1:00 pm IST, down 0.6% on the day, down 30.9% over a year. Its 52-week range is ₹745 to ₹1,104. The live price is in the app.

₹752.70 −0.6% today
−30.9% over 1 year · NSE, as of 13 Oct 2026, 1:00 pm IST
60 month-end closes, 31 Oct 2021 to 30 Sep 2026, adjusted for splits and bonuses
52-week range2% of the way up
Low ₹745High ₹1,104

What is Fortis Healthcare's market cap?

Fortis Healthcare's market capitalisation is about ₹57,169 crore: what it would cost to buy every share at today's price. That makes it the 82nd largest mid cap company we cover.

₹57,169 Cr Mid Cap82nd largest mid cap company
Mid Cap means the companies ranked 101 to 250 by size, under SEBI's rules. Shares in issue are worked out from the market cap and the price. What market cap tells you →

Key facts

From the exchange
Symbol
NSE: FORTIS
ISIN
INE061F01013
Cap bucket
Mid Cap, 82nd largest by market cap
Industry (NSE)
Healthcare › Healthcare Services › Hospital
Listed since
2007
Futures and options
Traded

Is Fortis Healthcare overvalued?

Cheap, with low confidence: no valuation within 120 days; P/E 56.6 vs peers 78.6 (3rd of 9); P/B 6.5 vs peers 10.2 (3rd of 8).

Valuation

Latest price and trailing 12 months
P/E 56.65
vs peers 78.6 · 3rd of 9
Price divided by last year's earnings per share: how many years of today's profit you pay for. Learn more →
P/B 6.50
vs peers 10.2 · 3rd of 8
Price divided by book value per share: what you pay for each rupee of net assets on the balance sheet. Learn more →
Market cap ₹57,169 Cr
Total market value of all shares, in ₹ crore. Learn more →
Dividend yield 0.1%
vs peers 0.3% · 5th of 6
Last year's dividends as a share of today's price. Learn more →
PEG (vendor) 23.90
vs peers 18.1 · 4th of 5
P/E divided by the vendor's earnings growth figure, which it does not disclose; a P/E adjusted for how fast profits grow. Learn more →
PEG on our 3-year EPS growth 2.70
P/E divided by the 3-year EPS growth rate from the stored accounts. Learn more →
3 models could be judged
Skipped — Fair value, EPV, Graham number, Graham value, Lynch, Owner earnings: no valuation stored

Our valuation range

🔒 Pro
Value range, implied growth at today's price, and the nine models behind it: in the app.

Is Fortis Healthcare a quality business?

Quality score 38.4, 5th of 9 in its peer set; CAUTION on 28 of 30 flags judged.

Quality and risk

Data as of 13 Oct 2026
Business quality Not available
The kind of business, which sets the yardstick it is judged by. Learn more →
Quality score 38.4
vs peers 47.6 · 5th of 9
Returns, margins, leverage and consistency against its peers, out of 100. Learn more →
Risk level CAUTION
28 of 30 flags judged
From flags on debt, earnings quality, dilution and price swings. Learn more →

Profitability

ROE 2.1%
vs peers 10.5% · 8th of 9
Return on equity: profit as a share of shareholders' money. Learn more →
ROCE 4.0%
vs peers 11.7% · 9th of 9
Return on capital employed: operating profit as a share of all the capital in the business, debt and equity. Learn more →
Profit margin 10.9%
vs peers 7.7% · 3rd of 9
Profit after everything, as a share of revenue. Learn more →
EPS ₹14.10
Trailing 12 months
Profit for each share over the last 12 months.

Scorecard

🔒 Pro
Health scores and red flags with their values and history: in the app.
See the scorecard →
Inside the app

Get a sneak peek of Valarth

Start freeStart free
A Valarth stock page: the share price with its chart and 52-week range, valuation and profitability figures, and a scorecard of health checks.
Stock pagePrice, valuation, profitability and a scorecard of health checks for every company, each figure explained.
The Valarth stock screener: a table of companies with price, market cap, P/E, P/B, PEG, EPS and ROE, and filters down the left.
ScreenerEvery listed company, filtered on 212 figures, each with a plain-language lesson beside it.
The Valarth AI Screener answering 'Which companies will benefit from India's Project 75 submarine programme?' with a basket of four naval shipbuilders and a written thesis.
AI ScreenerAsk a question in plain English, like which companies benefit from India's Project 75. It reads the intent, builds the screen and writes the thesis.
A Valarth business-model card for State Bank of India, with a plain-language summary and statements verified against the filing.
Business modelHow a company makes money and what can hurt it, each statement checked against its annual report.
Valarth's Before the Bell edition, with the day's headline, regulator notes and sector moves.
Before the BellA morning edition before the market opens: what moved, which rule changed, and what it means for your holdings.

Has Fortis Healthcare made money for shareholders?

Mixed: −30.9% over one year and +23.9% a year over five years.

Shareholder returns

1-year return −30.9%
Price only
What the share price did over the last 12 months. Learn more →
5-year return +23.9% a year
Price only
Yearly average price return over five years, bonuses and splits adjusted. Learn more →
Wealth destroyer No
Five-year total return — price CAGR on bonus- and split-adjusted closes plus the dividend yield — below the 7% a bank fixed deposit paid. Learn more →

Returns

3Y and 5Y are yearly averages
1W
−0.9%
1M
−14.0%
3M
−21.4%
6M
−10.9%
1Y
−30.9%
3Y
+33.6%
5Y
+23.9%

Does Fortis Healthcare pay a dividend?

Yes. Fortis Healthcare's dividend yield is 0.13% at the latest price; the last payout was ₹1.00 a share, ex-dividend 24 Jul 2026.

Dividends

Per share, by ex-dividend date
Dividend yield0.13%
The past 12 months' dividends as a share of today's price.
24 Jul 2026 · Final₹1.00
25 Jul 2025 · Final₹1.00
24 Jul 2024 · Final₹1.00
20 Jul 2023 · Final₹1.00
Payout ratio🔒 In the app
The share of profit paid out as dividends; a very high share leaves little to reinvest.
Dividend growth, 5 years🔒 In the app
How fast the dividend per share has grown a year.
Years without a miss🔒 In the app
How many years in a row a dividend has been paid.

Is Fortis Healthcare growing?

Revenue 3 years 12.8% a year; profit 3 years 20.9% a year; revenue 5 years 8.8% a year.

Growth

Statements through FY2026 (Mar-26)
Revenue 3 years 12.8% a year
vs peers 20.0% · 9th of 9
Compound annual growth of revenue over three years. Learn more →
Profit 3 years 20.9% a year
vs peers 11.1% · 3rd of 9
Compound annual growth of net profit over three years. Learn more →
Revenue 5 years 8.8% a year
Compound annual growth of revenue over five years. Learn more →
Profit 5 years 13.6% a year
Compound annual growth of net profit over five years. Learn more →
EPS 3 years 20.9% a year
Growth in earnings per share, so dilution counts against the company. Learn more →
EPS 5 years Not available
Growth in earnings per share over five years, so dilution counts against the company. Learn more →
P/E vs own history -5.0%
vs peers 0.9% · 3rd of 7
Today's P/E against its own 5-year median; negative is cheaper than its history. Learn more →

How did Fortis Healthcare do last quarter?

Fortis Healthcare reported revenue of ₹2,545 Cr, up 17.2% on a year earlier and a net profit of ₹273 Cr, up 31.5% in the Jun 2026 quarter.

Latest quarter

Jun 2026
Revenue, latest quarter₹2,545 Cr
+17.2% on a year earlier
What the company took in over the quarter.
Net profit, latest quarter₹273 Cr
+31.5% on a year earlier
What was left for shareholders after every cost and tax.

How does Fortis Healthcare compare with its peers?

Compared with 8 Hospital; 3rd of 9 on P/E; 5th of 9 on quality score.

Compared with 8 Hospital

8 companies

Fortis Healthcare against its peers

Largest 8 of 8 peers, by market cap
CompanyMarket capP/EP/BROEROCE1YQuality 🔒Rank 🔒
Fortis Healthcare Ltd₹57,169 Cr56.66.52.1%4.0%−30.9%
Apollo Hospitals Enterprise Ltd₹1.1 L Cr55.210.716.0%17.5%+1.4%
Manipal Health Enterprises Ltd₹89,321 Cr93.8—6.9%8.4%+1.8%
Max Healthcare Institute Ltd₹84,284 Cr59.010.58.3%10.3%−24.3%
Aster DM Quality Care Ltd₹59,221 Cr113.28.89.6%10.9%−3.0%
Global Health Ltd₹35,206 Cr63.46.413.2%15.9%−3.9%
Narayana Hrudayalaya Ltd₹34,582 Cr42.812.621.0%18.4%−3.8%
Krishna Institute of Medical Sciences Ltd₹29,577 Cr138.310.211.3%12.6%−1.3%
Dr Agarwals Health Care Ltd₹15,065 Cr101.96.51.9%5.0%−8.5%
Peer median—78.610.210.5%11.7%−1.7%
Market cap in rupees crore; P/E and P/B on the latest price; 1Y is the price return over a year. A dash is a figure that does not apply or is not reported.

Full peer comparison

🔒 Pro
Every peer, every figure, the ranks and the quality and forensic scores side by side: in the app.

Who owns Fortis Healthcare?

Fortis Healthcare is held by promoters 31.2%, foreign institutions 25.2%, domestic institutions 32.2%.

Shareholding pattern

Latest filing, percent of shares
Promoters31.2%
The founders and controlling group.
Foreign institutions25.2%
Overseas funds investing through the FPI route.
Domestic institutions32.2%
Indian insurers, banks, pension and mutual funds together.
Mutual funds25.8%
Indian mutual fund schemes; part of domestic institutions.
Retail and others3.3%
Individual investors and everyone else.
Promoter shares pledged🔒 In the app
Promoter shares given as collateral for loans; a high share is a risk to watch.
Holding trend🔒 In the app
Whether promoters, foreign funds and mutual funds have been adding or selling over recent quarters.

What do analysts say about Fortis Healthcare?

17 analysts cover Fortis Healthcare, and the consensus is buy. A consensus is a count of opinions, not a forecast; read it beside the numbers.

Analyst consensus

17 analysts
ConsensusBuy
The rating most covering analysts give the share.
Average target price🔒 In the app
The mean of the analysts' 12-month price targets.
Upside to target🔒 In the app
How far the target sits above or below today's price.
Share rating it a buy🔒 In the app
The share of covering analysts with a buy rating.

What does Fortis Healthcare do and what is it sensitive to?

The filings describe the company as providing hospital and medical care services, with patients as its primary customers. Sensitive to: interest rates on borrowings.

Business-model card

None · 36 verified
3Revenue
4Channels
2Regulators
3Reg. dependencies
3Sensitivities
3Costs
4Geographies

The filings describe the company as providing hospital and medical care services, with patients as its primary customers. Revenue is recognised from inpatient hospital services, hospital management fees and outpatient services, and the consolidated filing also reports a Diagnostic business as a second segment.

Revenue by segment

Year ended March 31, 2026 (consolidated)
Healthcare83.6%
Diagnostics16.4%

Revenue engine

3 verified
Inpatient hospital services and management fees from hospitals
Revenue is recognised over the period services are performed. Interpretation: this is the hospital bed-and-service line plus fees earned for managing hospitals.
Outpatient hospital services
Revenue is recognised at the point the patient actually receives the service, so it is booked per visit or procedure.
Diagnostic business (consolidated group segment)
The group reports Healthcare and Diagnostic as two reportable segments. The excerpts give no revenue split between them.

Customers & channels

4 verified
Patients
The company deals with patients, who are its primary customers; the excerpts state no revenue share for this group.
Foreign patients visiting Indian hospitals
Foreign nationals visiting India for care are part of the patient base. Interpretation: this is a cross-border demand channel that earns foreign currency.
Physician networks
Management plans to strengthen physician networks as part of its growth strategy. Interpretation: doctor referrals feed patient volumes.
1 more statement
Collection centres
Fees paid to collection centres appear as an expense line. Interpretation: they act as a sample and patient collection channel the company pays per fee.

Regulators

2 verified
Pollution control boards
Govern the protocols for disposal of medical waste generated by hospital operations.
Trademark registry
Registration of the Fortis brand and allied trademarks in the company's name runs through the trademark registry.

Regulatory dependencies

3 verified
Margin capping and tariff control
Interpretation: a cap on hospital or diagnostic margins or a tariff order would reduce revenue per patient and per test without a change in volume.
Transfer pricing regulations
Management expects the transfer pricing study to show arm's-length pricing and no impact on tax expense or tax provision. A challenge would move tax cost.
SEBI investigation (pending)
The investigation involves erstwhile promoters and promoter group companies. Management believes any action would not have a significant material impact because provisions were made earlier.

Sensitivities

3 verified
Interest rates on borrowings
Rate rise lowers profit: a 50 basis point increase reduces profit or loss by 901.47 lakhs in the latest year and 871.53 lakhs in the prior year, with the reverse for a decrease.
Foreign currency (USD, EUR)
Limited exposure because the company earns up to 10% of revenue in foreign currency from international patients; partly hedged naturally by foreign receivables and payables.
Allowance for doubtful trade receivables
Bad-debt allowance of 5,953.82 lakhs in FY2025 versus 6,180.45 lakhs in FY2024; rising patient-payment defaults reduce profit.

Cost inputs

3 verified
Professional and consultation fees to doctors
Largest cost line in the listed expenses; rose from 27,165.71 lakhs to 36,115.07 lakhs. Interpretation: doctor fees scale with patient and procedure volume.
Salaries, wages and bonus
Employee cost of 1,05,458.75 lakhs in FY2025 versus 1,01,046.36 lakhs in FY2024.
Medical reagents from equipment vendors
Under supplier agreements the group gets equipment free of cost, but reagents must be bought from those specific vendors only; the vendor may replace equipment at its discretion.

Geographies

4 verified
India (national operations)
The company has national presence across about 8 states; all revenue is from India.
Subsidiary Dubai lab (100% owned)
International lab in Dubai; samples are sent from international centres to Agilus reference labs in India for processing.
Joint venture Nepal labs (50:50)
Labs in Kathmandu and Biratnagar that send samples to India for processing.
1 more statement
International diagnostic client base
Diagnostic international network serves clients across the SAARC region, Sub-Saharan Africa, Southeast Asia, CIS, Gulf and the Middle East.
Each statement is checked word for word against the None annual report; the passages are in the app.

What changed recently?

Q1 FY2027 results filed (6 Aug 2026).

Change log

8 entries · newest first
  1. Results filedQ1 FY2027 results filed.
  2. Corporate actionDividend - Re 1 Per Share.
  3. Results filedQ4 FY2026 results filed.
  4. Results filedQ3 FY2026 results filed.
  5. Results filedQ2 FY2026 results filed.
  6. Results filedQ1 FY2026 results filed.
  7. Corporate actionDividend - Re 1 Per Share.
  8. Results filedQ4 FY2025 results filed.
Get alerts →Sign in to be told when any of these change.

What this page does not tell you

What could not be judged, and why. Never empty.
  • Models not runFair value, EPV, Graham number, Graham value, Lynch, Owner earnings: no valuation stored.
  • FlagsCAUTION on 28 of 30 flags judged; 3 red; 2 could not be judged.
  • Data gapsBusiness quality, EPS 5 years: not available yet.
Not applicable to this company · 1
  • Altman ZAltman Z is a manufacturing model; a service business has no inventory or plant turnover for it to read.

What this page rests on

✓10 years of annual statements, through FY2026 (Mar-26)✓10 quarters of results✓233 months of month-end prices, adjusted for bonuses and splits○no valuation of ours yet✓business-model card None · 36 verified

Questions people ask

What is Fortis Healthcare's share price today?

Fortis Healthcare last traded at ₹752.70 on the NSE, as of 13 Oct 2026, 1:00 pm IST, down 0.6% on the day, down 30.9% over a year. Its 52-week range is ₹745 to ₹1,104. The live price is in the app.

What is Fortis Healthcare's market cap?

Fortis Healthcare's market capitalisation is about ₹57,169 crore: what it would cost to buy every share at today's price. That makes it the 82nd largest mid cap company we cover.

Is Fortis Healthcare Ltd a large cap, mid cap or small cap?

Fortis Healthcare Ltd (FORTIS) is a mid cap company in AMFI's classification for Jan-Jun 2026. SEBI's buckets go by rank on six-month average market capitalisation: the top 100 are large caps, 101 to 250 mid caps, the rest small caps.

What is Fortis Healthcare Ltd's P/E ratio?

56.65, vs peers 78.6 · 3rd of 9. Price divided by last year's earnings per share: how many years of today's profit you pay for.

Is Fortis Healthcare Ltd overvalued?

Cheap, with low confidence: no valuation within 120 days; P/E 56.6 vs peers 78.6 (3rd of 9); P/B 6.5 vs peers 10.2 (3rd of 8).

How does Fortis Healthcare Ltd make money?

The filings describe the company as providing hospital and medical care services, with patients as its primary customers. Revenue is recognised from inpatient hospital services, hospital management fees and outpatient services, and the consolidated filing also reports a Diagnostic business as a second segment.

Who are Fortis Healthcare Ltd's peers?

Compared with 8 Hospital: Apollo Hospitals Enterprise Ltd, Manipal Health Enterprises Ltd, Max Healthcare Institute Ltd, Aster DM Quality Care Ltd, Global Health Ltd and 3 more. The app shows how they compare on every figure.

Is this investment advice?

No. Valarth is a research and learning tool and is not a SEBI-registered investment adviser or research analyst. The figures come from the company's filings and the exchanges; what to do with them is your call.

How did Fortis Healthcare do last quarter?

Fortis Healthcare reported revenue of ₹2,545 Cr, up 17.2% on a year earlier and a net profit of ₹273 Cr, up 31.5% in the Jun 2026 quarter.

Who owns Fortis Healthcare?

Fortis Healthcare is held by promoters 31.2%, foreign institutions 25.2%, domestic institutions 32.2%.

Does Fortis Healthcare pay a dividend?

Yes. Fortis Healthcare's dividend yield is 0.13% at the latest price; the last payout was ₹1.00 a share, ex-dividend 24 Jul 2026.

What do analysts say about Fortis Healthcare?

17 analysts cover Fortis Healthcare, and the consensus is buy. A consensus is a count of opinions, not a forecast; read it beside the numbers.

More mid cap companies

Kalyan Jewellers India LtdKALYANKJIL · ₹58,572 CrJindal Stainless LtdJSL · ₹58,278 CrIndian Overseas BankIOB · ₹58,251 CrSchaeffler India LtdSCHAEFFLER · ₹57,704 CrNational Aluminium Company LtdNATIONALUM · ₹57,083 CrBiocon LtdBIOCON · ₹56,444 CrGeneral Insurance Corporation of IndiaGICRE · ₹55,474 CrBerger Paints India LtdBERGEPAINT · ₹54,825 Cr
All companies, by market cap →

Everything on Fortis Healthcare, and 6,621 other companies, with 212 filters and the full peer tables

See Fortis Healthcare in the app →See pricing